Neogen Corp

Neogen Corp Stock Forecast & Price Prediction

Live Neogen Corp Stock (NEOG) Price
$17.64

1

Ratings

  • Buy 0
  • Hold 1
  • Sell 0
Disclaimer : The analyst ratings and price forecast data are provided by Tradefeeds. The data is sourced from Wall Street analysts and other experienced experts. The figures presented are solely a forecast and not a guarantee of future price performance. The information presented is not a recommendation to buy or sell the stock.

Stock Price

$17.64

P/E Ratio

P/E Ratio not available for NEOG

Volume Traded Today

$1.4M

Dividend

Dividends not available for NEOG

52 Week High/low

24.10/14.44

Neogen Corp Market Cap

$3.82B

🛑 Alert: These ten stocks could have higher potential than $NEOG 🛑

Before you buy NEOG you’ll want to see this list of ten stocks that have huge potential. Want to see if NEOG made the cut? Enter your email below

NEOG Summary

The Neogen Corp (NEOG) share price is expected to increase by 7.71% over the next year. This is based on calculating the average 12-month share price estimate provided by 1 stock analysts who have covered NEOG. Price targets range from $19.00 at the low end to $19.00 at the high end. The current analyst consensus for NEOG is a hold. Please note analyst price targets are not guaranteed and could be missed completely.

NEOG Analyst Ratings

NEOG is a stock in Health Care which has been forecasted to be worth $19.00 as an average. On the higher end, the forecast price is $19.00 USD by david westenberg from Piper Sandler and on the lower end NEOG is forecasted to be $19.00 by david westenberg from Piper Sandler.

NEOG stock forecast by analyst

Analyst/Firm

Rating

Price Target

Change

Date

david westenberg
Piper Sandler

Hold

$19.0

rated

Jan 18, 2024
timothy daley
Wells Fargo

Buy

$28.0

maintained

Aug 14, 2023
brandon vazquez
William Blair

Buy

None

upgraded

Nov 22, 2022
gerry sweeney
Roth Capital

Hold

$37.5

maintained

Jul 23, 2020
mark connelly
Stephens

Buy

$44.0

reiterated

Jul 14, 2020
kevin ellich
Craig-Hallum

Buy

$78.0

reiterated

Jul 24, 2019
drew jones
Stephens

Hold

$75.0

reiterated

Oct 3, 2018
anton brenner
Roth Capital

Buy

$68.0

reiterated

Sep 28, 2016
charles haff
Craig-Hallum

Hold

$65.0

downgraded

Dec 22, 2015
brian weinstein
William Blair

Hold

None

maintained

Nov 20, 2015
paul knight
KeyBanc

Hold

$46.0

rated

Dec 19, 2013
steven crowley
Craig-Hallum

Hold

None

downgraded

Jul 24, 2013
elliott schlang
Wellington Shields

Sell

None

downgraded

Jul 24, 2013

NEOG Company Information

Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods. The segment offers its products primarily to milling and grain, meat and poultry, prepared foods and ingredients, fruits and vegetables, seafood, dairy, beverage, water, healthcare, traditional culture media markets, food service, and dietary supplements markets. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products, and genomics testing services marketed through veterinarians, retailers, livestock producers, and animal health product distributors, for the animal safety market. The segment offers its products for companion animal veterinarians; livestock producers, veterinarians, and breed associations; retailers; breeding and genetics companies; diagnostic labs and universities; distributors; and other manufacturers and government agencies. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.

NEOG
Neogen Corp (NEOG)

When did it IPO

1989

Staff Count

2,640

Country

United States

Sector/Industry

Healthcare/Diagnostics & Research

CEO

Mr. John Edward Adent

Market Cap

$3.82B

Neogen Corp(NEOG) Financial Data

In 2023, NEOG generated $0 in revenue, which was a increase of 0.00% from the previous year. This can be seen as a signal that NEOG's business is growing, and its share price could be worth more in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.

Revenue From 2019

N/A

Revenue From 2020

N/A

0.00 %
From Previous Year

Revenue From 2021

N/A

0.00 %
From Previous Year

Revenue From 2022

N/A

0.00 %
From Previous Year
  • Revenue TTM $918.7M
  • Operating Margin TTM 0.08%
  • Gross profit TTM $406.0M
  • Return on assets TTM 0.01%
  • Return on equity TTM 0.00%
  • Profit margin 0.01282%
  • Book value 14.54%
  • Market capitalisation $3.82B
  • Revenue for 2020 N/A
  • Revenue for 2021 N/A
  • Revenue for 2022 N/A
  • EPS this year 0.10
  • EPS next year N/A

Neogen Corp(NEOG) Latest News

... ...

Similar Stocks to Neogen Corp NEOG

🛑 Alert: These ten stocks could have higher potential than $NEOG 🛑

Before you buy NEOG you’ll want to see this list of ten stocks that have huge potential. Want to see if NEOG made the cut? Enter your email below

...

NEOG Frequently asked questions

The highest forecasted price for NEOG is $19.00 from david westenberg at Piper Sandler.

The lowest forecasted price for NEOG is $19.00 from david westenberg from Piper Sandler

The NEOG analyst ratings consensus are 0 buy ratings, 1 hold ratings, and 0 sell ratings.